Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
134
datasets available to search
ShareScore release 0.9.0
Dataset results
134 results for “Sofosbuvir”
A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)
ClinicalTrials.gov study NCT03005210. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir
ClinicalTrials.gov study NCT03063879. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders
ClinicalTrials.gov study NCT02120300. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
ClinicalTrials.gov study NCT02336139. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)
ClinicalTrials.gov study NCT02358044. IPD Sharing: YES. Countries: 0. Publications: 5.
HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
ClinicalTrials.gov study NCT03282474. IPD Sharing: NO. Countries: 1. Publications: 3.
Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients
ClinicalTrials.gov study NCT03200184. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium
ClinicalTrials.gov study NCT02799355. IPD Sharing: UNDECIDED. Countries: 1. Publications: 13.
Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis C
ClinicalTrials.gov study NCT04159246. IPD Sharing: YES. Countries: 1. Publications: 5.
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02292719. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
ClinicalTrials.gov study NCT02206932. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection
ClinicalTrials.gov study NCT02992457. IPD Sharing: NO. Countries: 1. Publications: 2.
Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)
ClinicalTrials.gov study NCT02624063. IPD Sharing: NO. Countries: 1. Publications: 1.
Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4
ClinicalTrials.gov study NCT02405013. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)
ClinicalTrials.gov study NCT03062423. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment
ClinicalTrials.gov study NCT03042520. IPD Sharing: NO. Countries: 2. Publications: 1.
Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT02485080. IPD Sharing: NO. Countries: 1. Publications: 3.
An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant
ClinicalTrials.gov study NCT02165189. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C
ClinicalTrials.gov study NCT03416491. IPD Sharing: NO. Countries: 1. Publications: 1.
Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)
ClinicalTrials.gov study NCT02478229. IPD Sharing: Not stated. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.